Ackermans & Van Haaren NV (DE:B3K)
FRANKFURT:B3K
Holding DE:B3K?
Track your performance easily

Ackermans & Van Haaren NV (B3K) Income Statement

8 Followers

Ackermans & Van Haaren NV Income Statement

Last quarter (Q ), Ackermans & Van Haaren NV's total revenue was €1.13B, an increase of 43.16% from the same quarter last year. In Q, Ackermans & Van Haaren NV's net income was €292.00M. See Ackermans & Van Haaren NV’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 4.20B€ 4.40B€ 4.31B€ 3.91B€ 4.27B€ 4.47B
Cost of Revenue
€ -431.00M€ 2.87B€ 2.70B€ 2.03B€ 2.79B€ 2.29B
Gross Profit
€ 3.10B€ 1.53B€ 1.62B€ 1.88B€ 1.48B€ 2.18B
Operating Expense
€ -1.04B€ 1.24B€ 1.86B€ 1.73B€ 1.16B€ 1.77B
Operating Income
€ 1.32B€ 292.27M€ 334.19M€ 146.79M€ 322.78M€ 409.97M
Net Non Operating Interest Income Expense
€ -175.00M€ -26.86M€ -34.28M€ -57.02M€ -22.36M€ -64.28M
Other Income Expense
€ 120.00M-----
Pretax Income
€ 1.06B€ 889.59M€ 591.66M€ 324.36M€ 575.63M€ 513.97M
Tax Provision
€ -108.00M€ 82.08M€ 79.45M€ 46.74M€ 61.76M€ 72.19M
Earnings From Equity Interest Net Of Tax
€ 117.00M-----
Net Income Common Stockholders
€ 790.00M€ 708.65M€ 406.81M€ 229.79M€ 394.90M€ 289.64M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ -2.88B€ 4.11B€ 3.98B€ 3.76B€ 3.95B€ 4.06B
Net Income From Continuing And Discontinued Operation
€ 806.00M€ 708.65M€ 406.81M€ 229.79M€ 394.90M€ 289.64M
Normalized Income
-€ 380.19M€ 382.84M€ 196.91M€ 302.93M€ 279.26M
Interest Expense
-€ 37.37M€ 33.69M€ 39.58M€ 35.33M€ 61.14M
EBIT
€ 1.24B€ 926.96M€ 625.35M€ 363.93M€ 610.96M€ 575.10M
EBITDA
€ 648.00M€ 1.29B€ 975.91M€ 714.70M€ 953.91M€ 872.15M
Currency in EUR

Ackermans & Van Haaren NV Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis